Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome

Details for Australian Patent Application No. 2004251075 (hide)

Owner White Mountain Pharma, Inc.

Inventors White, Hillary D.; Gyurik, Robert J.

Agent FB Rice

Pub. Number AU-B-2004251075

PCT Pub. Number WO2005/000236

Priority 10/464,310 18.06.03 US

Filing date 15 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 2 December 2010

International Classifications

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000236 Priority application(s): WO2005/000236

17 September 2009 Assignment before Grant

  Trustees of Dartmouth College; Bentley Pharmaceuticals, Inc. The application has been assigned to White Mountain Pharma, Inc.

2 December 2010 Application Accepted

  Published as AU-B-2004251075

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251079-Method and apparatus for preparation of genetically transformable plant tissue

2004251070-Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same